Archives 2017

May 31, 2017

Ralexar Therapeutics Initiates Phase 2b Study of ALX-101 in Patients with Atopic Dermatitis

Please reload

NeXeption

640 Lee Road, Ste 110

Wayne, PA 19087

T +1 484.318.2988

F +1 484.324.7949

Nexeption Logo